Mouse Anti-PARP4 Recombinant Antibody (CBYC-A1018) (CBMAB-A4651-YC)

Sung, H. Y., Han, J., Chae, Y. J., Ju, W., Kang, J. L., Park, A. K., & Ahn, J. H. (2023). Identification of a novel PARP4 gene promoter CpG locus associated with cisplatin chemoresistance. BMB reports, 56(6), 347.

Frigon, L., & Pascal, J. M. (2023). Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP. Nucleic Acids Research, 51(22), 12492-12507.

Kim, J. H., Lee, S., & Hong, Y. C. (2022). Modification Effect of PARP4 and ERCC1 Gene Polymorphisms on the Relationship between Particulate Matter Exposure and Fasting Glucose Level. International journal of environmental research and public health, 19(10), 6241.

Kirby, I. T., Person, A., & Cohen, M. (2021). Rational design of selective inhibitors of PARP4. RSC Medicinal Chemistry, 12(11), 1950-1957.

Kim, J. H., & Hong, Y. C. (2020). Modification of PARP4, XRCC3, and RAD51 gene polymorphisms on the relation between bisphenol A exposure and liver abnormality. International journal of environmental research and public health, 17(8), 2794.

Cirello, V., Colombo, C., Pogliaghi, G., Proverbio, M. C., Rossi, S., Mussani, E., ... & Fugazzola, L. (2019). Genetic variants of PARP4 gene and PARP4P2 pseudogene in patients with multiple primary tumors including thyroid cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 816, 111672.

Prawira, A., Munusamy, P., Yuan, J., Chan, C. H. T., Koh, G. L., Shuen, T. W. H., ... & Lee, A. S. G. (2019). Assessment of PARP4 as a candidate breast cancer susceptibility gene. Breast Cancer Research and Treatment, 177, 145-153.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols